# Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

> **NCT03970967** · NA · TERMINATED · sponsor: **Alpha Tau Medical LTD.** · enrollment: 1 (actual)

## Conditions studied

- Breast Carcinoma
- Metastatic Breast Cancer
- Invasive Breast Cancer
- Distant Metastases.Pathology

## Interventions

- **DEVICE:** Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

## Key facts

- **NCT ID:** NCT03970967
- **Lead sponsor:** Alpha Tau Medical LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-28
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Difficulty in recruiting patients
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03970967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03970967, "Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03970967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*